Back
Regeneron Pharmaceuticals Inc (REGN)
BiotechnologyREGN · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$833.98
+0.65%Weekly undervalued picks (like REGN)
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$41.48
ROE
14.5%
Gross margin
43.9%
Debt/Equity
8.61x
Revenue growth
19.0%
Regeneron Pharmaceuticals Inc — company intelligence
Earnings surprises
Q2 2026$14.29 vs $10.47 est+36.5%
Q1 2026$9.47 vs $9.12 est+3.9%
Q4 2025$11.44 vs $10.83 est+5.7%
Q3 2025$11.83 vs $9.78 est+21.0%
Analyst consensus · 37 analysts
26 Buy11 Hold0 Sell
Updated Aug 24, 2026
Insider activity · 90 days
0 buys1 sellnet -200 shares
Guarini Kathrynother 400 · Aug 10, 2026
Zoghbi Huda Yother 800 · Aug 10, 2026
RYAN ARTHUR FSell 200 · Jul 2, 2026
Recent SEC filings
4 — Insider transaction reportAug 21, 2026
4 — Insider transaction reportAug 20, 2026
4 — Insider transaction reportAug 12, 2026
Latest news
Regeneron: Why I Still See Upside After The Rally — SeekingAlpha · 22h ago
$100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Today — Benzinga · 1d ago
Sanofi: Trump's Vaccine Policy Won't Break The Story — SeekingAlpha · 1d ago
Oil Shipper Hits New High; Three Stocks Also Near Pivots — Yahoo · 4d ago
How Moderna’s Historic Short Squeeze Upended the AI Chip Trade — Yahoo · 5d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks (like REGN)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.